Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
by
Gabelli, Sandra
, Thompson, Philip
, Miller, Michelle
in
1-Phosphatidylinositol 3-kinase
/ Binding sites
/ Cancer
/ FDA approval
/ Immunological diseases
/ isoform selectivity
/ Isoforms
/ Kinases
/ Lymphoma
/ Mutation
/ p110
/ p85
/ Phosphatidylinositol
/ phosphatidylinositol 3-kinase
/ PI3Kα
/ PI3Kβ
/ PI3Kγ
/ PI3Kδ
/ PIK3CA
/ Protein structure
/ Proteins
/ Review
/ Roles
/ Thrombosis
/ Tumors
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
by
Gabelli, Sandra
, Thompson, Philip
, Miller, Michelle
in
1-Phosphatidylinositol 3-kinase
/ Binding sites
/ Cancer
/ FDA approval
/ Immunological diseases
/ isoform selectivity
/ Isoforms
/ Kinases
/ Lymphoma
/ Mutation
/ p110
/ p85
/ Phosphatidylinositol
/ phosphatidylinositol 3-kinase
/ PI3Kα
/ PI3Kβ
/ PI3Kγ
/ PI3Kδ
/ PIK3CA
/ Protein structure
/ Proteins
/ Review
/ Roles
/ Thrombosis
/ Tumors
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
by
Gabelli, Sandra
, Thompson, Philip
, Miller, Michelle
in
1-Phosphatidylinositol 3-kinase
/ Binding sites
/ Cancer
/ FDA approval
/ Immunological diseases
/ isoform selectivity
/ Isoforms
/ Kinases
/ Lymphoma
/ Mutation
/ p110
/ p85
/ Phosphatidylinositol
/ phosphatidylinositol 3-kinase
/ PI3Kα
/ PI3Kβ
/ PI3Kγ
/ PI3Kδ
/ PIK3CA
/ Protein structure
/ Proteins
/ Review
/ Roles
/ Thrombosis
/ Tumors
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
Journal Article
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
2019
Request Book From Autostore
and Choose the Collection Method
Overview
Phosphatidylinositol 3-kinases (PI3Ks) are important therapeutic targets for the treatment of cancer, thrombosis, and inflammatory and immune diseases. The four highly homologous Class I isoforms, PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ have unique, non-redundant physiological roles and as such, isoform selectivity has been a key consideration driving inhibitor design and development. In this review, we discuss the structural biology of PI3Ks and how our growing knowledge of structure has influenced the medicinal chemistry of PI3K inhibitors. We present an analysis of the available structure-selectivity-activity relationship data to highlight key insights into how the various regions of the PI3K binding site influence isoform selectivity. The picture that emerges is one that is far from simple and emphasizes the complex nature of protein-inhibitor binding, involving protein flexibility, energetics, water networks and interactions with non-conserved residues.
This website uses cookies to ensure you get the best experience on our website.